IRCT20220708055414N1已完成3 期
Evaluation Renoprotective Effect SGLT2 inhibitors on Prognosis of Transplant Kidney Patients
Orchidpharmed0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age>18 years old
- •Stable state of renal function for at least the last three months
- •Consent to participate in the study
- •Sustained immunosuppressive therapy for at least three months
- •Transplantation > one year ago
- •Diabetic patient according to the criteria of the American Diabetes Association
排除标准
- •Surgery or medical conditions that affect the rate of Absorption,Distribution and Metabolism or Excretion of the drug
- •More than one transplant
- •Pregnancy or Breastfeeding
- •Allergy or Contraindications
- •Type 1 diabetes
- •Participation in any clinical study within 3 months before the initial dose
- •Frequent UTI
- •History of Alcohol use in the 12 months prior to the initial dose
- •Donating blood or Removing 400 ml of blood is required 8 weeks before the initial dose
研究者
相似试验
已完成
不适用
ong-term renoprotective effect of SGLT2 inhibitorstype 2 diabetes melllitusJPRN-UMIN000034387ephrology Division, JA Toride Medical Center60
招募中
2 期
Comparison of the renoprotective effects of SGLT2 inhibitor (Empagliflozin) in diabetic and non-diabetic kidney transplantation patientsIRCT20130812014333N168Kermanshah University of Medical Sciences28
招募中
不适用
Investigation of renal protective effects of SGLT2 inhibitor by using renal doppler ultrasonographyJPRN-UMIN000028438Ogawa Red Cross Hospital60
招募中
Unknown
The Renal Protective Effect Of SGLT2 Inhibitor Drug In Diabetics Patient Who Are Undergoing Per cutaneous Coronary Interventions.CTRI/2023/10/058896GSM Institute of Pharmaceutical Science
Unknown
4 期
Effect of SGLT2 inhibitor on Renal Function and Urinary [TIMP-2] x [IGFBP7] in Patients Hospitalized for Acute Heart Failure; A Randomized Controlled TrailAcute kidney injury and urinary [TIMP-2] x [IGFBP7] in patient hospitalized for acute heart failureAcute kidney injury, urinary [TIMP-2] x [IGFBP7], nephrocheck, acute heart failure, acute decompensated heart failure, SGLT2 inhibitor, renal function, biomarkerTCTR20221003002/A66